Churchill supports Cornell Capital's buyout of Advancing Eyecare

Churchill is an investment-specialist affiliate of Nuveen, the asset manager of TIAA.

1 August 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.